At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas
In Brief
A Phase 2 clinical trial evaluating tivozanib and laboratory biomarker analysis for Recurrent Adult Soft Tissue Sarcoma and 2 related conditions. Completed, enrolled 58 participants across 5 sites.
Detailed Summary
This study is for patients who have been diagnosed with soft tissue sarcoma that has spread (metastasized) or that is not eligible for removal by surgery. The purpose of this study is to determine how soft tissue sarcomas respond to treatment with an investigational drug called tivozanib. In some lab and clinical studies, tivozanib has been shown to interfere with the growth of some types of tumors. The study will also evaluate how safe the study treatment is by observing how many and what kind of adverse events (side effects) participants experience.
Study Details
Timeline
Interventions
Given PO
Correlative studies